| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccf08ae7fc46e83066dab0ad82fa0862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b41e6bacd73e79e024526cb3fba2fbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41a639aa11b9b2f8063a3e6b8b22b557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9035e6f15336515272f9feb7186a03d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c9aaae830c5bb58770c51c5606a876c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_862c22167176c1251c0acfd6f39caca0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-745 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
| filingDate |
2005-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04ffdf15ee8e019cf5274045b274da0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac80ae04c9f7e519e4a528ce55755cb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adf2fb4546336741f2dc02552389ae82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb4510f9dfd5d8ac22a9d4b2b883caa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_007b6545dbd063353f8cca1a04a0a84d |
| publicationDate |
2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005095638-A2 |
| titleOfInvention |
A kit for measuring the thrombin generation in a sample of a patient’s blood or plasma |
| abstract |
The invention provides a kit for measuring the thrombin generation in a sample of a patient's blood or plasma, or in a sample of clotting factors. The kit contains lyophilized tissue factor/phospholipid-complex and a lyophilized mixture containing a thrombin-substrate and CaCl2. The invention also provides processes for preparing the reagents for the kit. The kit can be used in a method for measuring the thrombin generation in a sample, wherein it is possible to detect changes in thrombin generation kinetics, for example after administration of inhibitor bypassing agents to a patient who has developed inhibitors to an exogenous clotting factor such as Factor VIII. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3363912-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9091700-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018151602-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10845346-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8138308-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016196207-A1 |
| priorityDate |
2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |